Efficacy of a Coaching Program to Promote Physical Activity and Reduce Sedentary Behavior After a COPD Hospitalization

Efficacy of a Coaching Program to Promote Physical Activity and Reduce Sedentary Behavior After a COPD Exacerbation That Require Hospitalization

Patients with COPD are more inactive and more sedentary than subjects of the same age and patients with other chronic diseases. This inactivity and sedentary behavior is accentuated after hospitalizations due to a COPD exacerbation, and it increases the risk for future hospitalizations and mortality. Therefore, there is a need for intervention to promote physical activity and to reduce sedentary behavior after these events. The present study aims to evaluate the efficacy of a coaching program to promote physical activity and reduce sedentary behavior in patients with COPD who have suffered a hospitalization due to a COPD exacerbation. Sixty-six COPD patients admitted to the hospital will be recruited during 18 months. Physical activity, sedentary behaviors, as well as other clinical and functional parameters will be evaluated after hospital discharge. Patients will be then randomized to an intervention and control group (1:1). The intervention group will receive an individualized coaching program. During a motivational interview an experienced physiotherapist will asses participant's usual exercise habits, possible barriers and facilitators, self-efficacy and motivation to increase physical activity and reduce sedentary time. Based on these data (and baseline physical activity/sedentary information) an individualized, progressive program with specific goals setting and self-monitoring will be established (patients will be active participants and decision makers in this process). The control group will receive the usual care during follow-up. Physical activity, sedentary behaviors, as well as the clinical and functional variables will be evaluated again at 12 weeks in both patients' groups.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Previous diagnosis of COPD according to spirometric criteria (post-bronchodilator FEV1 / FVC less than 70%)
  2. Smoking exposure> 10 paq/year.
  3. Age greater than 40 years.
  4. Hospitalization due to a COPD exacerbation
  5. Written informed consent.

Exclusion Criteria:

  1. Patients needing the care of an Intensive Care Unit.
  2. Patients who have been hospitalized more than once for a COPD exacerbation in the previous 12 months (at least 3 months from last discharge).
  3. Patients with continuous oxygen therapy who do not have a portable source before admission.
  4. Patients with severe hypoxemia at rest (SpO2 <85% at rest) at discharge
  5. Mental incapacity, severe comorbidity, general fragility or advanced age that could substantially difficult patient's participation in the study.
  6. Patients who need mechanical aids for walking.
  7. Patients participating in a pulmonary rehabilitation program.
  8. Difficulty understanding Spanish / Catalan.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Patients in the intervention group will receive an individualized coaching program to increase physical activity and reduce sedentary behavior during 12 weeks
The intervention group will receive an individualized coaching program. During a motivational interview an experienced physiotherapist will asses participant's usual exercise habits, possible barriers and facilitators, self-efficacy and motivation to increase physical activity and reduce sedentary time. Based on these data (and baseline physical activity/sedentary information) an individualized, progressive program with specific goals setting and self-monitoring will be established (patients will be active participants and decision makers in this process).
No Intervention: Control group
Patients in the control group will receive the standard care for patients with COPD during 12 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in steps per day
Time Frame: Baseline and 12 weeks
Steps per day will be objectively measured with an accelerometer
Baseline and 12 weeks
Change in the number of active periods per day
Time Frame: Baseline and 12 weeks
Number of periods spent standing, walking or shuffling objectively measured with an accelerometer
Baseline and 12 weeks
Change in time spend in light and moderate physical activity
Time Frame: Baseline and 12 weeks
Time spend in light and moderate physical activity (1.5-3 and 3-6 METS) objectively measured with an accelerometer
Baseline and 12 weeks
Change in time spend in sedentary behavior
Time Frame: Baseline and 12 weeks
Time spend in sedentary behavior (sitting or lying) objectively measured with an accelerometer
Baseline and 12 weeks
Breaks in sedentary behaviour
Time Frame: Baseline and 12 weeks
Number of transitions from sedentary behavior to standing or walking objectively measured with an accelerometer
Baseline and 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in exercise capacity
Time Frame: Baseline and 12 weeks
Distance walked in the 6-minute walk test
Baseline and 12 weeks
Change in muscle force
Time Frame: Baseline and 12 weeks
Quadriceps muscle force tested with a hand-held dynamometer
Baseline and 12 weeks
Change in patient's quality of life
Time Frame: Baseline and 12 weeks
patient's quality of life measured using the St. George's Respiratory Questionnaire (SGRQ) anbd the COPD assesment test (CAT)
Baseline and 12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in patients's anxiety and depression
Time Frame: Baseline and 12 weeks
Patient's anxiety and depression measured using the Hospital Anxiety and Depression scale (HADS)
Baseline and 12 weeks
Change in dyspnoea during daily activities
Time Frame: Baseline and 12 weeks
Dyspnoea during daily activities measures using the London Chest Activity of Daily Living scale (LCADL)
Baseline and 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

March 1, 2017

Primary Completion (Anticipated)

September 1, 2018

Study Completion (Anticipated)

December 1, 2018

Study Registration Dates

First Submitted

March 14, 2017

First Submitted That Met QC Criteria

March 14, 2017

First Posted (Actual)

March 21, 2017

Study Record Updates

Last Update Posted (Actual)

March 21, 2017

Last Update Submitted That Met QC Criteria

March 14, 2017

Last Verified

March 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

IPD will not be shared

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Clinical Trials on Physical activity and sedentary behavior coaching program

3
Subscribe